ZYME · Categories · Form 4
ZYME - SEC Form 4 insider transactions
Zymeworks Inc. (ZYME) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ZYME
- SEC Form 4 filed by EVP, General Counsel Schneider Paul R4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Schayowitz Adam4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Platshon Scott4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Stafford Kristin4 - Zymeworks Inc. (0001937653) (Issuer)
- EVP & Chief Operating Officer Hollywood Mark converted options into 17,666 shares and sold $138,762 worth of shares (6,120 units at $22.67), increasing direct ownership by 10% to 132,913 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Cherry Brian N4 - Zymeworks Inc. (0001937653) (Issuer)
- EVP & Chief Medical Officer Smith Jeffrey T L sold $211,090 worth of shares (9,310 units at $22.67) and converted options into 17,666 shares, increasing direct ownership by 46% to 26,708 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Ciongoli Gregory Austin4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Neu Kelvin4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Landry Robert E4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Cesano Alessandra4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Campoy Carlos4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Mahony Susan4 - Zymeworks Inc. (0001937653) (Issuer)
- Chief Scientific Officer Moore Paul Andrew converted options into 17,666 shares and sold $216,759 worth of shares (9,560 units at $22.67), increasing direct ownership by 20% to 48,497 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Chair & CEO Galbraith Kenneth converted options into 64,000 shares and sold $689,819 worth of shares (30,424 units at $22.67), increasing direct ownership by 17% to 226,842 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- EVP, Chief Bus & Fin Officer Patterson Leone D was granted 459 shares (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- EVP & Chief Medical Officer Smith Jeffrey T L sold $264,471 worth of shares (10,538 units at $25.10) and converted options into 20,000 shares, increasing direct ownership by 106% to 18,352 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Chair & CEO Galbraith Kenneth converted options into 114,334 shares and sold $1,363,841 worth of shares (54,343 units at $25.10), increasing direct ownership by 45% to 193,266 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Chief Scientific Officer Moore Paul Andrew converted options into 37,168 shares and sold $504,699 worth of shares (20,110 units at $25.10), increasing direct ownership by 73% to 40,391 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Chair & CEO Galbraith Kenneth converted options into 100,000 shares and sold $1,284,311 worth of shares (47,528 units at $27.02), increasing direct ownership by 65% to 133,275 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Director Ciongoli Gregory Austin was granted 415,000 shares, increasing direct ownership by 565% to 488,500 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Landry Robert E4 - Zymeworks Inc. (0001937653) (Issuer)
- Director Ecor1 Capital, Llc exercised 5,086,480 in-the-money shares at a strike of $0.00 and covered exercise/tax liability with 41 shares (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by EVP, Chief Bus & Fin Officer Patterson Leone D4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Moore Paul Andrew4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by EVP & Chief Medical Officer Smith Jeffrey T L4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Chair & CEO Galbraith Kenneth4 - Zymeworks Inc. (0001937653) (Issuer)
- Chief Scientific Officer Moore Paul Andrew converted options into 37,166 shares and sold $316,391 worth of shares (21,200 units at $14.92), increasing direct ownership by 217% to 23,333 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- Chair & CEO Galbraith Kenneth converted options into 114,332 shares and sold $855,017 worth of shares (57,291 units at $14.92), increasing direct ownership by 240% to 80,803 units (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- EVP & Chief Medical Officer Smith Jeffrey T L converted options into 20,000 shares and sold $165,807 worth of shares (11,110 units at $14.92) (SEC Form 4)4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Large owner Ecor1 Capital, Llc4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Miller Derek John Michael4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Campoy Carlos4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Cesano Alessandra4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Neu Kelvin4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Davidson Nancy4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Cox Troy4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Mahony Susan4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Director Gallagher Neil4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by EVP, Chief Bus & Fin Officer Patterson Leone D4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4 filed by Gallagher Neil4 - Zymeworks Inc. (0001937653) (Issuer)
- SEC Form 4: Josephson Neil converted options into 5,885 shares and sold $20,045 worth of shares (2,475 units at $8.10) as part of a pre-agreed trading plan, increasing direct ownership by 31% to 14,449 units to satisfy tax liability4 - Zymeworks BC Inc. (0001403752) (Issuer)
- SEC Form 4 filed by Moore Paul Andrew4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Josephson Neil was granted 1,525 shares, increasing direct ownership by 16% to 11,039 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Klompas Neil A was granted 1,525 shares, increasing direct ownership by 11% to 14,801 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4 filed by Astle Christopher4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Klompas Neil A converted options into 5,208 shares and sold $20,496 worth of shares (2,979 units at $6.88) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 13,276 units (for withholding tax)4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Josephson Neil converted options into 2,395 shares, increasing direct ownership by 34% to 9,514 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4 filed by Galbraith Kenneth4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Josephson Neil bought $71,386 worth of shares (5,000 units at $14.28), increasing direct ownership by 236% to 7,119 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Josephson Neil was granted 65 shares, increasing direct ownership by 3% to 2,119 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Polverino Anthony J. was granted 74 shares, increasing direct ownership by 0.20% to 36,407 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Klompas Neil A was granted 277 shares, increasing direct ownership by 3% to 11,047 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4 filed by Josephson Neil4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Polverino Anthony J. exercised 4,900 units of Common Shares at a strike of $15.00, increasing direct ownership by 16% to 36,333 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Tehrani Ali exercised 44,991 units of Common Shares at a strike of $4.26 and sold $1,619,676 worth of Common Shares (44,991 units at $36.00)4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Tehrani Ali exercised 12,669 units of Common Shares at a strike of $4.31 and sold $457,635 worth of Common Shares (12,669 units at $36.12)4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: O'Driscoll Kathryn was granted 510 units of Common Shares, increasing direct ownership by 9% to 6,350 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Josephson Neil was granted 461 units of Common Shares, increasing direct ownership by 29% to 2,054 units4 - Zymeworks Inc. (0001403752) (Issuer)
- SEC Form 4: Priour James was granted 510 units of Common Shares, increasing direct ownership by 25% to 2,513 units4 - Zymeworks Inc. (0001403752) (Issuer)